Investors may be trying to do their homework on shares of Theralase Technologies Inc. (TSXV:TLT). Investors looking for value may be focusing on the Piotroski F-Score. Theralase Technologies Inc. has a current Piotroski F-Score of 2. The mission of the F-Score is to help spot companies with strengthening balance sheets, and to weed out poor performers. The Piotroski F-Score is named after its developer Joseph Piotroski. The F-Score uses nine different variables based on a company’s financial statement. One point is provided to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong while a stock with a score from 0-2 would be viewed as weak.
Every investor strives to conquer the markets. Many investors may have to work through different trading strategies to find one that works for them. Some individuals may be looking to monitor stock price momentum by looking at different historical data. Theralase Technologies Inc. (TSXV:TLT) currently has a 6 month price index of 0.75581. The six month price index is simply measured by dividing the current share price by the share price six months ago. A ratio above one indicates an increase in share price over the six month period. A ratio below one indicates that the price has decreased over that specific period.
Taking a look at some volatility information, Theralase Technologies Inc.’s 12 month volatility is presently 66.413500. The 6 month volatility is 88.071000, and the 3 month is spotted at 106.546600. Checking on historical volatility can help gauge how much the stock price has fluctuated over the given period of time. Although past volatility action may help predict the future volatility of a stock, it may also be greatly different when taking into account other factors that may be driving price action during the period of time.
Investors may be looking to track FCF or Free Cash Flow scores for Theralase Technologies Inc. (TSXV:TLT). Free cash flow represents the amount of cash that a company has generated for shareholders after paying off expenses and investing in growth. FCF may be a very useful way to help measure the financial health of a specific company. At the time of writing, Theralase Technologies Inc. TSXV:TLT has an FCF quality score of -7.611660. The free quality score helps estimate the stability of free cash flow. FCF quality is calculated as the 12 ltm cash flow per share over the average of the cash flow numbers. Looking at this score, it is generally considered that the lower the ratio, the better. Currently, Theralase Technologies Inc. TSXV:TLT has an FCF score of 0.706359. The FCF score is determined by merging free cash flow stability with free cash flow growth. In general, a higher FCF score value would represent high free cash flow growth.
Diving in a bit further, we can take a quick look at the Q.i. (Liquidity) Value. Theralase Technologies Inc. has a present Q.i. value of 50.00000. This value ranks stocks using EBITDA yield, FCF yield, earnings yield and liquidity ratios. The Q.i. value may help spot companies that are undervalued. A larger value would represent low turnover and a higher chance of shares being mispriced. A lower value may indicate larger traded value meaning more sell-side analysts may cover the company leading to a smaller chance shares are priced improperly.